Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients
Sebert, J.L.; Marie, A.; Kuntz, D.; Marie, P.; Gueris, J.; Smadja, A.; Fournier, A.; Quichaud, J.
Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(7-9): 535-541
1981
ISSN/ISBN: 0035-2659 PMID: 7291931 Document Number: 172617
vitamin compounds to the basic dialytic treatment of renal osteodystrophy is of contestable interest. Because 1) optimum conditions of dialysis without D vitamin addition prevent efficiently the progress of severe gyperparathyroidism and osteomalacia 2) the D vitamin compunds could render the phosphatemia control more difficult thus contributing to aggravate the histologic lesions of hyperparathyroidism.